Tamoxifen Treatment of Breast Cancer Cells: Impact on Hedgehog/GLI1 Signaling

The selective estrogen receptor (ER) modulator tamoxifen (TAM) has become the standard therapy for the treatment of ER+ breast cancer patients. Despite the obvious benefits of TAM, a proportion of patients acquire resistance to treatment, and this is a significant clinical problem. Consequently, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Villegas, Victoria E., Rondón-Lagos, Milena, Annaratone, Laura, Castellano, Isabella, Grismaldo, Adriana, Sapino, Anna, Zaphiropoulos, Peter G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813171/
https://www.ncbi.nlm.nih.gov/pubmed/26927093
http://dx.doi.org/10.3390/ijms17030308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813171/
https://www.ncbi.nlm.nih.gov/pubmed/26927093
http://dx.doi.org/10.3390/ijms17030308

Ejemplares similares